What's Going on With Broadcom Stock?

Parkev Tatevosian (CFA) of The Motley Fool published a June 17 video (using June 15, 2024 afternoon prices) discussing what recent developments could mean for Broadcom (NASDAQ: AVGO) investors. The piece notes that Broadcom was not included in The Motley Fool Stock Advisor's latest top-10 picks despite the firm recommending the stock, discloses the author's lack of personal position and potential affiliate compensation, and contains no new financial metrics, guidance, or other market-moving information.

Analysis

Market structure: Broadcom (AVGO) sits as a beneficiary if AI-driven data‑center spending broadens beyond GPUs — winners include diversified ASIC/firmware providers and large foundries; losers are small analog and legacy CPU suppliers with limited AI content. Competitive dynamics favor players with integrated software/firmware bundles (pricing power + gross margin expansion), shifting share away from commodity ASICs; expect high‑end silicon demand to keep spot pricing firm for 6–18 months, tightening supply for leading nodes. Cross‑asset: stronger semiconductor cash flows compress IG tech credit spreads by 20–50bp and lift HY sentiment; expect higher equity vols around NVDA/AVGO earnings and transient USD strength on risk‑on flows.

Risk assessment: Tail risks include anti‑trust action on M&A (probability ~10–15% over 12–24 months), China export restrictions disrupting advanced node access, and a semiconductor inventory correction (20–30% downside to consensus over 3–6 months in worst case). Immediate (days) risk is event volatility; short term (weeks–months) is guidance/turns in hyperscaler spend; long term (years) depends on AI TAM sustainability and Broadcom’s software integration executing. Hidden dependencies: customer concentration (top 5 customers >30% rev) and embedded software renewal cadence; catalysts are Broadcom earnings, NVDA data‑center results, and any regulatory filings in next 90 days.

Trade implications: Direct play — establish a modest core long in AVGO (2–3% portfolio) and use short‑dated protective puts (30–90 day) sized 25% of position to cap downside; pair trade — long AVGO / short NVDA equal notional for 3–6 months to harvest mean reversion if NVDA outperforms by >15% in 30 days. Options strategies: write 30‑day covered calls 5% OTM on AVGO for 1–2% monthly yield and buy 9–12 month 25% OTM LEAPS if conviction in AI TAM persists. Rotate 5–10% from pure AI ETFs (e.g., SOXX/NVDA-heavy) into diversified semis (AVGO) and quality infrastructure names (NDAQ) over next 30–60 days.

Contrarian angles: Consensus prizes NVDA’s growth and may underweight AVGO’s cash conversion and software margin leverage; if NVDA multiple extends another 20–30% without commensurate revenue acceleration, expect >10% mean reversion within 3 months. Historical parallels: leadership shifts in prior cycles (2009–2012) show diversified, cash‑generative chipmakers outperformed after peak hype. Unintended consequence — crowded NVDA longs could spike IV and create cheap entry points in AVGO; mispricing window likely within 1–3 months after next earnings print.

Key Decisions for Investors

• Establish a 2–3% portfolio long in AVGO within 30 days; hedge with 30–90 day puts sized to 25% of the position (stop-loss target −10% absolute).
• Implement a 3–6 month pair trade: long AVGO / short NVDA on equal dollar notional if NVDA outperforms AVGO by >15% over any 30‑day window; close if spread reverts by 5% or after 90 days.
• Write 30‑day covered calls 5% OTM on existing AVGO holdings to collect ~1–2% monthly yield; if assigned proceed to sell 1–2% of position on continued outperformance.
• Trim NVDA exposure by 5–10% if it represents >8% portfolio weight and redeploy proceeds into AVGO and NDAQ over the next 30–60 days, targeting a 15–25% 6–12 month upside for reallocation candidates.